Tezepelumab trials for COPD

All Tezepelumab trials · All COPD trials

Phase breakdown

Recruiting trials studying Tezepelumab for COPD

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 305 locations
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 276 locations
• Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
  NCT05507242 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Tezepelumab for COPD?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.